Welcome to our dedicated page for Mudrick Capital Acquisition Ii news (Ticker: MUDSU), a resource for investors and traders seeking the latest updates and insights on Mudrick Capital Acquisition Ii stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Mudrick Capital Acquisition Ii's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Mudrick Capital Acquisition Ii's position in the market.
Mudrick Capital Acquisition Corporation II (Nasdaq: MUDSU) received a notification from Nasdaq on May 28, 2021, indicating non-compliance with Listing Rule 5250(c)(1) due to the delayed filing of its Q1 2021 Form 10-Q, which was due by May 24, 2021. The company now has until July 26, 2021, to present a compliance plan, with a potential extension to November 22, 2021. The company has filed its Q1 2021 Form 10-Q on June 2, 2021, and expects to regain compliance with Nasdaq requirements.
FAQ
What is the market cap of Mudrick Capital Acquisition Ii (MUDSU)?
